Meds Coupons

View Deals

8 Coupons

  • eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .

    cancer patients� lives are being put at risk because savage tory cuts to the nhs are delaying the start of their treatment by 18 months. .

      .